Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
Filter by:
Project name
Lead Institution
Summary
Funders
UCL
The aim of the study is to find out how many care home staff and residents have been infected with COVID-19, to inform decisions around the best approach to COVID-19 testing in the future.
Department of Health and Social Care, UK Health Security Agency
University of Birmingham
This study aims to understand, at a qualitative and quantitative level, immune response durability in 'real-life settings' of different vaccination regimens for individuals who are over 80 years of age living in the community in the UK.
The National Core Studies Programme (NCS) immunity
University of Birmingham
This study aims to understand, at a qualitative and quantitative level, immune response durability in 'real-life settings' of different vaccination regimens in individuals with a diagnosis of chronic lymphocytic leukaemia (CLL).
National Core Studies Programme (NCS) immunity
DuRaCoV study: The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants
Imperial College London
The DuRaCoV study aims to understand, at a qualitative and quantitative level, immune response durability in 'real-life settings' of different vaccination regimens, with or without prior infection.
UK Research and Innovation via the National Core Studies Immunity Programme
University of Oxford
To establish the optimal strategy for booster vaccination, this study is embarking on a programme of work that will advance our ability to identify individuals who have, or are at risk of mounting, a low response to COVID-19 vaccination.
Medical Research Council
King's College London
The key objective of the SOAP study is to address two main questions: (1) is there an immune signature of COVID19 which is specific to cancer patients; and (2) do recovered cancer patients carry a post-infection immunological legacy?
Cancer Research UK (CRUK), King’s College London, Guy’s and St Thomas’ NHS Foundation NHS Trust , GSTT Charity, Blood Cancer UK and Leukaemia and Lymphoma Society (LLS)
Oxford University Hospital
The PREPARE project aims to understand the risk COVID-19 poses for patients with blood cancers using information from participants from the RUDY study. The first wave of the project will focus on myeloma patients who have joined the RUDY study.
Blood Cancer UK Research Collaborative
University of Glasgow
OCTAVE DUO, an extension of the OCTAVE trial, is investigating if a third vaccine dose for people with weakened immune systems gives a stronger immune response than two doses.
National Institute for Health Research (NIHR), UK Research and Innovation (UKRI)
University of Cambridge
This study will investigate the effect of obesity on COVID-19 vaccine effectiveness, as part of existing weight loss programmes in the obesity clinic in Cambridge University Hospital NHS Trust and King's College London.
UK Research and Innovation
University of Edinburgh
Building on our earlier work, we engaged with a range of patient, public, community, professional and health policy groups who told us the following questions are the most important to them:
UK Research and Innovation, The Alan Turing Institute